Increased lipid peroxidation in growth hormone-deficient adult patients

Neuroendocrinology Letters

Volumn 27, Issue 1-2, 2006, Pages 225-230

  Kokoszko, Agnieszka ^a,b   Karbownik, Malgorzata ^a,b   Lewiński, Andrzej ^a,b  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

^b POLISH MOTHER S MEMORIAL HOSPITAL RESEARCH INSTITUTE   (Poland)

Author keywords

Growth hormone (GH) deficiency in adults; Insulin tolerance test (ITT); Lipid peroxidation (LPO); Oxidative stress

Indexed keywords

CHOLESTEROL; GLUCOSE; GROWTH HORMONE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MALONALDEHYDE;

ADULT; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; BLOOD SAMPLING; BLOOD VESSEL; BODY MASS; BONE DENSITY; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; CRANIOPHARYNGIOMA; DISEASE SEVERITY; FEMALE; GROWTH HORMONE DEFICIENCY; HUMAN; HYPOPHYSIS ADENOMA; INSULIN TOLERANCE TEST; LIPID BLOOD LEVEL; LIPID PEROXIDATION; LUMBAR SPINE; MALE; METABOLIC PARAMETERS; OXIDATIVE STRESS; RISK FACTOR; VOLUNTEER;

EID: 33745675698     PISSN: 0172780X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Ahmad AM, Thomas J, Clewes A, Hopkins MT, Guzder R, Ibrahim H, et al. Effects of growth hormone replacement on parathyroid hormone sensitivity and bone mineral metabolism. J Clin Endocrinol Metab 2003; 88(6):2860-8.
2. Carroll PV, Drake WM, Maher KT, Metcalfe K, Shaw NJ, Dunger DB, et al. Comparison of continuation or cessation of growth hormone (GH) therapy on body composition and metabolic status in adolescents with severe GH deficiency at completion of linear growth. J Clin Enclocrinol Metab 2004; 89(8):3890-5.
3. Colao A, Di Somma C, Rota F, Pivonello R, Savanelli MC, Spiezia S, et al. Shortterm effects of growth hormone (GH) treatment or deprivation on cardiovascular risk parameters and intima-media thickness at carotid arteries in patients with severe GH deficiency. J Clin Enclocrinol Metab 2005; 90(4):2056-62.
4. Dreher D, Junod AF. Role of oxygen free radicals in cancer development. Eur J Cancer 1996; 32A(1):30-8.
5. Dröge W. Free radicals in the physiological control of cell function. Physiol Rev 2002; 82(1):47-95.
6. ElsasserTH, Kahl S, MacLeod C, Nicholson B, Sartin JL, Li C. Mechanisms underlying growth hormone effects in augmenting nitric oxide production and protein tyrosine nitration during endotoxin challenge. Endocrinology 2004; 145(7):3413-23.
7. Evans LM, Davies JS, Anderson RA, Ellis GR, Jackson SK, Lewis MJ, et al. The effect of GH replacement therapy on endothelial function and oxidative stress in adult growth hormone deficiency. EurJ Enclocrinol 2000; 142:254-62.
8. Gitto E, Karbownik M, Reiter RJ, Tan DX, Cuzzocrea S, Chiurazzi P, et al. Effects of melatonin treatment in septic newborns, Pediatr Res 2001; 50(6):756-60.
9. Gitto E, Reiter RJ, Cordaro SP, La Rosa M, Chiurazzi P, Trimarchi G, et al. Oxidative and inflammatory parameters in respiratory distress syndrome of preterm newborns: beneficial effects of melatonin. Am J Perinatol 2004; 21(4):209-16.
10. Gola M, Bonadonna S, Doga M, Giustina A. Clinical review: Growth hormone and cardiovascular risk factors. J Clin Endocrinol Metab 2005; 90(3):1864-70.
11. Karbownik M, Tan D, Manchester LC, Reiter RJ. Renal toxicity of the carcinogen 6-aminolevulinic acid: antioxiclant effects of melatonin. Cancer Lett 2000a; 161(1):1-7.
12. Karbownik M, Reiter RJ, Garcia JJ Tan D. Melatonin reduces phenylhydrazine-incluced oxidative damage to cellular membranes: evidence for the involvement of iron. Int J Biochem Cell Biol 2000b; 32(10):1045-54.
13. Karbownik M, Reiter RJ, Burkhardt S, Gitto E, Tan D-X, Lewin̈ski A. Melatonin attenuates estradiol-incluced oxidative damage to DNA: relevance for cancer prevention. Exp Biol Med 2001; 226(7):707-12.
14. Maison AM, Griffin S, Nicoue-Beglah M, Haddad N, Balkau B, Chanson P. Impact of growth hormone (GH) treatment on cardiovascular risk factors in GH-cleficient adults: a metaanalysis of blinded, randomized, placebo-controlled trials. J Clin Endocrinol Metab 2004; 89(5): 2192-9.
15. Marnett LJ. Lipid peroxiclation - DNA damage by malondialclehyde. Mutat Res 1999; 424(1-2):83-95.
16. Ozbey N, Telci A, Cakatay U, Yurci A, Molvalilar S. Determination of oxidative protein and lipid damage in adult hypopituitary patients with GH deficiency. J Enclocrinol Invest 2003; 26(10):1001-7.
17. Sener G, Satyroglu H, Ozer Sehirli A, Kacmaz A. Protective effect of aqueous garlic extract against oxidative organ damage in a rat model of thermal injury. Life Sci 2003; 73(1):81-91.
18. Sheppard MC. Growth hormone - from molecule to mortality. Clin Med 2004; 4(5):437-40.
19. Svensson J, Bengtsson BA, Rosen T, Oden A, Johannsson G. Malignant disease and cardiovascular morbidity in hypopituitary adults with or without growth hormone replacement therapy. J Clin Endocrinol Metab 2004; 89(7):3306-12.
20. Thum T, Tsikas D, Frolich JC, Borlak J. Growth hormone induces eNOS expression and nitric oxide release in a cultured human enclothelial cell line. FEBS Lett 2003; 555(3):567-71.
21. Tunali T, Sener G, Yarat A, Emekli N. Melatonin reduces oxidative damage to skin and normalizes blood coagulation in a rat model of thermal injury. Life Sci 2005; 76(11):1259-65.
22. Youn YK, Suh GJ, Jung SE, Oh SK, Demling R. Recombinant human growth hormone decreases lung and liver tissue lipid peroxidation and increases antioxiclant activity after thermal injury in rats. J Burn Care Rehabil 1998; 19(6):542-8.